Firdevs Aksoy
Overview
Explore the profile of Firdevs Aksoy including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
21
Citations
157
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Metan G, Ciftcioglu A, Saba R, Kilic A, Ozdemir K, Cag Y, et al.
Indian J Hematol Blood Transfus
. 2025 Feb;
41(1):75-88.
PMID: 39917507
We aimed to investigate the approaches for antifungal prophylaxis (AFP) and antifungal treatment in breakthrough invasive fungal diseases (IFDs) under AFP in high-risk hematology patients. Patients ≥ 18-years who received...
2.
Esendagli D, Sari N, Akhan S, Arslan S, Dogan Ontas I, Yilmaz G, et al.
Med Princ Pract
. 2025 Jan;
:1-10.
PMID: 39870064
Objective: We are still in search of new therapeutic options for COVID-19 to prevent new infections, enable fast recovery, and reduce the long-lasting symptoms or sequelae. This study aimed to...
3.
Ozer V, Gonenc Cekic O, Bulbul O, Aydin D, Bulut E, Aksoy F, et al.
West J Emerg Med
. 2024 Dec;
25(6):975-984.
PMID: 39625772
Introduction: The workload of physicians increased due to the number of patients presenting with suspicion of coronavirus 2019 (COVID-19) and the prolonged wait times in the emergency department during the...
4.
Carmeli Y, Cisneros J, Paul M, Daikos G, Wang M, Torre-Cisneros J, et al.
Lancet Infect Dis
. 2024 Oct;
25(2):218-230.
PMID: 39389071
Background: There is a need for additional therapeutic options for serious infections caused by Gram-negative pathogens. In the phase 3, descriptive REVISIT study, we investigated the safety and efficacy of...
5.
Aslan A, Tabah A, Koylu B, Kalem A, Aksoy F, Erol C, et al.
J Antimicrob Chemother
. 2023 Jun;
78(7):1757-1768.
PMID: 37264485
Objectives: To uncover clinical epidemiology, microbiological characteristics and outcome determinants of hospital-acquired bloodstream infections (HA-BSIs) in Turkish ICU patients. Methods: The EUROBACT II was a prospective observational multicontinental cohort study....
6.
Buetti N, Tabah A, Loiodice A, Ruckly S, Aslan A, Montrucchio G, et al.
Crit Care
. 2022 Oct;
26(1):319.
PMID: 36258239
Background: The study aimed to describe the epidemiology and outcomes of hospital-acquired bloodstream infections (HABSIs) between COVID-19 and non-COVID-19 critically ill patients. Methods: We used data from the Eurobact II...
7.
Senol E, Cilli A, Gunen H, Sener A, Dumlu R, Odemis A, et al.
Turk Thorac J
. 2022 Feb;
22(4):339-345.
PMID: 35110252
Objective: To evaluate the rate of pneumococcal pneumonia (PP) among patients with community-acquired pneumonia (CAP) in Turkey and to investigate and compare features of PP and non-PP CAP patients. Material...
8.
Kaya S, Yilmaz G, Aydin M, Aksoy F, Koksal I
Infection
. 2019 Oct;
48(1):99-107.
PMID: 31656011
Purpose: To develop a practical scoring system to assist clinicians in differentiating leptospirosis and hantavirus infections, whose epidemiological, clinical, and laboratory characteristics are literally like identical twins. Methods: The study...
9.
Ozer V, Gunaydin M, Pasli S, Aksoy F, Gunduz A
Turk J Emerg Med
. 2019 May;
19(2):76-78.
PMID: 31073544
Introduction: Anthrax is a zoonosis affecting herbivorous animals. Its agent is Bacillus anthracis and it is gram positive, aerobic or facultative anaerobic, immobile and has a capsule in the polypeptide...
10.
Cag Y, Karabay O, Sipahi O, Aksoy F, Durmus G, Batirel A, et al.
PLoS One
. 2018 Sep;
13(9):e0204608.
PMID: 30256855
Sepsis is a severe clinical syndrome owing to its high mortality. Quick Sequential Organ Failure Assessment (qSOFA) score has been proposed for the prediction of fatal outcomes in sepsis syndrome...